Northwind Pharmaceuticals recalled 2,295 bottles of Sulfamethoxazole and Trimethoprim Tablets due to contamination risks. A foreign substance was detected in the packaging's auxiliary polyester coil, although no micro-organisms were found on the tablets. Consumers should stop using these products immediately and contact Northwind Pharmaceuticals for guidance.
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Northwind Pharmaceuticals LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Sulfamethoxazole and Trimethoprim are antibiotics used to treat various bacterial infections. Consumers buy this product for conditions like urinary tract infections and respiratory infections as it is effective against specific bacteria.
The hazard stems from a micro-organism detected in the packaging material, which poses a contamination risk. Although the tablets themselves were not contaminated, consumers should stop using the product to avoid any potential health risks linked to the packaging.
This recall is not part of a broader industry pattern.
The recall affects consumers who rely on this medication for treatment. They may face interruptions in their treatment while seeking alternatives or awaiting refunds, which could impact their health.
You can find the lot number printed on the label or the packaging of the medication, typically near the expiration date.
Allow 4-6 weeks for processing refunds or replacements after contacting Northwind Pharmaceuticals.
Keep a record of your purchase receipt, correspondence with the manufacturer, and any notifications received regarding the recall.
Recalled products include Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength. Packaged in 6-count, 10-count, 14-count, and 20-count bottles. Lot numbers include F118062503, F118062507, and other specified lots. Distributed nationwide.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.